Belimumab treatment holiday and treatment re-start study in lupus patients

Trial Identifier: 116027
Sponsor: GlaxoSmithKline
Start Date: May 2014
Primary Completion Date: December 2018
Study Completion Date: December 2018
Condition: Lupus

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
China Beijing, China, 100032
China Beijing, China, 100044
China, Anhui Hefei, Anhui, China, 230001
China, Jiangsu Suzhou, Jiangsu, China, 215006
China, Zhejiang Hangzhou, Zhejiang, China, 310009
Japan Chiba, Japan, 275-8580
Japan Ehime, Japan, 791-0295
Japan Hokkaido, Japan, 060-8604
Japan Miyagi, Japan, 980-8574
Japan Nagasaki, Japan, 857-1195
Japan Tokyo, Japan, 162-8655
Japan Tokyo, Japan, 104-8560
South Korea Daegu, South Korea, 700-721
South Korea Seoul, South Korea, 110-744
South Korea Seoul, South Korea, 150-713
South Korea Seoul, South Korea, 133-792
South Korea Suwon, Kyonggi-do, South Korea, 443-721
United States, California Los Angeles, California, United States, 90048
United States, New York Manhasset, New York, United States, 11030
United States, Texas Dallas, Texas, United States, 75246